{
  "trial_id": "NCT01302379",
  "trial_group": "obesity",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, BMI, Stage of breast cancer, Type of surgery, Time since diagnosis, Use of statins, Use of tamoxifen, Use of aromatase inhibitors, Menopausal status, Geographic accessibility, Communication ability, Preliminary bloodwork results, Renal function, Liver function, Heart function, Use of corticosteroids, Use of steroid hormone therapy, Use of thiazides, Use of \u03b2-blockers, Use of insulin, Use of other antidiabetic drugs, History of other cancers, Commitment to study requirements.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Body Mass Index",
          "BMI"
        ],
        [
          "Time Since Diagnosis",
          "Time since diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity"
      ],
      "remaining_candidate_features": [
        "Stage of breast cancer",
        "Type of surgery",
        "Use of statins",
        "Use of tamoxifen",
        "Use of aromatase inhibitors",
        "Menopausal status",
        "Geographic accessibility",
        "Communication ability",
        "Preliminary bloodwork results",
        "Renal function",
        "Liver function",
        "Heart function",
        "Use of corticosteroids",
        "Use of steroid hormone therapy",
        "Use of thiazides",
        "Use of \u03b2-blockers",
        "Use of insulin",
        "Use of other antidiabetic drugs",
        "History of other cancers",
        "Commitment to study requirements"
      ]
    },
    "processed-gen-response": "Age, BMI, Stage of breast cancer, Type of surgery, Time since diagnosis, Use of statins, Use of tamoxifen, Use of aromatase inhibitors, Menopausal status, Geographic accessibility, Communication ability, Preliminary bloodwork results, Renal function, Liver function, Heart function, Use of corticosteroids, Use of steroid hormone therapy, Use of thiazides, Use of \u03b2-blockers, Use of insulin, Use of other antidiabetic drugs, History of other cancers, Commitment to study requirements."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Breast Cancer Stage, Time Since Diagnosis, Type of Surgery, Use of Adjuvant Therapy, Baseline Insulin Levels, Baseline Glucose Levels, Baseline C-reactive Protein Levels, Baseline Bioavailable Testosterone Levels, Baseline Serum Hormone Binding Globulin Levels, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Time Since Diagnosis",
          "Time Since Diagnosis"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Breast Cancer Stage",
        "Type of Surgery",
        "Use of Adjuvant Therapy",
        "Baseline Insulin Levels",
        "Baseline Glucose Levels",
        "Baseline C-reactive Protein Levels",
        "Baseline Bioavailable Testosterone Levels",
        "Baseline Serum Hormone Binding Globulin Levels"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Body Mass Index, Breast Cancer Stage, Time Since Diagnosis, Type of Surgery, Use of Adjuvant Therapy, Baseline Insulin Levels, Baseline Glucose Levels, Baseline C-reactive Protein Levels, Baseline Bioavailable Testosterone Levels, Baseline Serum Hormone Binding Globulin Levels"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Menopausal Status, Breast Cancer Stage, Time Since Diagnosis, Chemotherapy Status, Radiation Therapy Status, Hormone Therapy Status, Statin Use, Tamoxifen Use, Aromatase Inhibitor Use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Time Since Diagnosis",
          "Time Since Diagnosis"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Male"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Menopausal Status",
        "Breast Cancer Stage",
        "Chemotherapy Status",
        "Radiation Therapy Status",
        "Hormone Therapy Status",
        "Statin Use",
        "Tamoxifen Use",
        "Aromatase Inhibitor Use"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Body Mass Index, Menopausal Status, Breast Cancer Stage, Time Since Diagnosis, Chemotherapy Status, Radiation Therapy Status, Hormone Therapy Status, Statin Use, Tamoxifen Use, Aromatase Inhibitor Use."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, BMI, race, ethnicity, education level, marital status, employment status, smoking status, medical history (diabetes, hypertension, cardiovascular disease), breast cancer stage, time since diagnosis, type of breast cancer treatment, menopausal status, use of hormone replacement therapy, use of statins, tamoxifen, or aromatase inhibitors.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Body Mass Index",
          "BMI"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Time Since Diagnosis",
          "time since diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male"
      ],
      "remaining_candidate_features": [
        "education level",
        "marital status",
        "employment status",
        "smoking status",
        "medical history (diabetes, hypertension, cardiovascular disease)",
        "breast cancer stage",
        "type of breast cancer treatment",
        "menopausal status",
        "use of hormone replacement therapy",
        "use of statins",
        "tamoxifen",
        "or aromatase inhibitors."
      ]
    },
    "processed-gen-response": "Age, BMI, race, ethnicity, education level, marital status, employment status, smoking status, medical history (diabetes, hypertension, cardiovascular disease), breast cancer stage, time since diagnosis, type of breast cancer treatment, menopausal status, use of hormone replacement therapy, use of statins, tamoxifen, or aromatase inhibitors."
  }
}